¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"first line therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
¿µ¹® Electric convulsive therapy(ECT) ÇÑ±Û Àü±â°æ·Ã¿ä¹ý
¼³¸í   
  ³ú¿¡ Àü±â ÀÚ±ØÀ» ÁÖ¾î ÀÎÀ§ÀûÀ¸·Î °æ·ÃÀ» À¯¹ßÇÔÀ¸·Î½á Á¤½Å º´À» Ä¡·áÇϴ ¹æ¹ý. Àü±â¼îÅ©¿ä¹ý(electroshock therapy)À̶ó°íµµ ÇÑ´Ù. 1938³â¿¡ ÀÌÅ»¸®¾ÆÀǠü¸¦·¹Æ¼¿Í ºñ´Ï¿¡ ÀÇÇØ ½ÃÀ۵Ǿú´Ù. ÀÛ¿ë±âÀüÀº È®½ÇÄ¡ ¾ÊÀ¸³ª ³úÀÇ ½ÅÁø´ë»ç, »ýÈ­ÇР¹× È¿¼Ò µî¿¡ º¯È­¸¦ ÀÏÀ¸Å²´Ù´Â »ý¹°ÇÐÀû, »ýÈ­ÇÐÀû Çм³ÀÌ À¯·ÂÇÏ´Ù.
  
  ÀûÀÀÁõÀ¸·Î °¡Àå È¿°úÀûÀΠº´Àº ¿ì¿ïÁõÀ¸·Î Æ¯È÷ ¿©¼º¿¡¼­ °»³â±â¿¡ È£¹ßÇϴ °»³â±â ¿ì¿ïÁõ, ¿ì¿ïÁõ°ú Á¶Áõ(¾ÆÁÖ ±âºÐÀÌ ÁÁÀº »óŰ¡ Áö¼ÓµÇ´Â Á¤½Åº´)ÀÌ ÀÏÁ¤ÇÑ Áֱ⸦ µÎ°í ¹Ýº¹Çϴ Á¶¿ïÁõ¿¡ Àß ¾²À̸ç, 80~90%¿¡¼­ È¿°ú°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • estrogen replacement therapy
    ¿¡½ºÆ®·Î°Õ´ëÄ¡¿ä¹ý
  • fever therapy
    ¹ß¿­¿ä¹ý
  • gene therapy
    À¯ÀüÀÚ¿ä¹ý
  • gene transfer therapy
    À¯ÀüÀÚÀ̽Ŀä¹ý
  • hypoglycemic shock therapy
    ÀúÇ÷´çÃæ°Ý¿ä¹ý, Àν¶¸°Ãæ°Ý¿ä¹ý
  • hypothermia therapy
    Àúü¿Â¿ä¹ý
  • hormone replacement therapy
    È£¸£¸ó´ëġġ·á
  • hormone therapy
    È£¸£¸ó¿ä¹ý
  • hyperbaric oxygen therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • implosive therapy
    ³»Æø¿ä¹ý
  • inhalation therapy
    ÈíÀÔ¿ä¹ý
  • intensity modulated radiation therapy
    °­µµº¯Á¶¹æ»ç¼±¿ä¹ý
  • interpersonal therapy
    ´ëÀοä¹ý
  • myofunctional therapy
    ±Ù(À°)±â´É¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gingival line
    ÀÕ¸ö¼±
  • gluteal line
    º¼±â±Ù¼±
  • gravitational skin line
    Áß·ÂÇǺμ±
  • growth line
    ¼ºÀå¼±
  • growth arrest line
    ¼ºÀåÁ¤Áö¼±
  • growth recovery line
    ¼ºÀåȸº¹¼±
  • heteroploid cell line
    À̼öü¼¼Æ÷°è
  • inbred line
    ¼ø°è
  • incremental line
    Áõ½Ä¼±
  • isoelectric line
    (¢¡base line) ¹ÙÅÁ¼±, ±âÁؼ±
  • isothermal line
    µî¿Â¼±
  • line
    ¼±, °è
  • lead line
    ³³¼±
  • life line
    »ý¸íÀüÈ­, »ý¸í±¸Á¶¼±
  • limiting line
    ÇѰ輱
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
  • hyperbaric oxygen therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • hyperbaric oxygenation therapy
    °í¾Ð»ê¼Ò¿ä¹ý(ÍÔäâß«áÈèþÛö)
  • immunization therapy
    ¸é¿ª¿ä¹ý(Øóæ¹èþÛö).
  • immunization therapy
    ¸é¿ª¿ä¹ý(¸é¿ª¿ä¹ý).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý(¡­åäð¤èþÛö).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • implosive therapy
    ³»ÆÄ Ä¡·á
  • inhalation therapy =i. treatment
    ÈíÀÔ ¿ä¹ý.
  • insulin shock therapy
    Àν¶¸°¼ï¿ä¹ý.
  • insulin therapy
    Àν¶¸°Ä¡·á, Àν¶¸°¿ä¹ý.
  • intensification therapy
    Áõ°­¿ä¹ý.
  • intensity modulated radiation therapy
    °­µµº¯Á¶ ¹æ»ç¼±Ä¡·á
  • photodynamic therapy
    ±¤¼±¿ªÇпä¹ý
  • photodynamic therapy
    ±¤¿ªÇÐÄ¡·á
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • first pharyngeal membrane
    ù°Àεθ·
  • first pharyngeal pouch
    ù°ÀεÎÁÖ¸Ó´Ï
  • first polar body
    ù°±ØÃ¼, Á¦ÀϱØÃ¼.
  • first polar body
    ù°±ØÃ¼
  • first polar body
    ÀÏÂ÷±ØÃ¼
  • first position
    Á¦ÀÏÀ§.
  • first posterior intercostal artery
    ù°µÚ°¥ºñ»çÀ̵¿¸Æ
  • first pouch
    ù°ÁÖ¸Ó´Ï
  • first premolar
    Á¦Àϼұ¸Ä¡(¡­á³Ï¿öÍ).
  • first rib
    ù°°¥ºñ»À
  • first set reaction
    ÀÏÂ÷°ÅºÎ¹ÝÀÀ
  • first set rejection
    1Â÷°ÅºÎ(¹ÝÀÀ).
  • first set rejection
    ÀÏÂ÷°ÅºÎ(¹ÝÀÀ).
  • first sound (of heart)
    ½ÉÀåÁ¦ÀÏÀ½.
  • first stage
    Á¦Àϱâ(ð¯ìéÑ¢).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Transverse line
    °¡·Î¼±
    [¿¾ ¿ë¾î] Ⱦ¼±
  • Soleal line
    °¡Áö¹Ì±Ù¼±
    [¿¾ ¿ë¾î] °¡Àڹ̱ټ±
  • Lateral supracondylar line
    °¡ÂʰüÀýÀ¶±âÀ§¼±
    [¿¾ ¿ë¾î] ¿ÜÃø°ú»ó¼±
  • Postaxillary line
    °Üµå¶ûµÚ¼±
    [¿¾ ¿ë¾î] Èľ׿ͼ±
  • Preaxillary line
    °Üµå¶û¾Õ¼±
    [¿¾ ¿ë¾î] Àü¾×¿Í¼±
  • Temporal line
    °üÀÚ¼±
    [¿¾ ¿ë¾î] ÃøµÎ¼±
  • Intertrochanteric line
    µ¹±â»çÀ̼±
    [¿¾ ¿ë¾î] ÀüÀÚ°£¼±
  • Pectineal line
    µÎµ¢±Ù¼±
    [¿¾ ¿ë¾î] Ä¡°ñ±Ù¼±
  • Pectineal line
    µÎµ¢»Àºø
    [¿¾ ¿ë¾î] Ä¡°ñ±Ù¼±
  • Posterior axillary line
    µÚ°Üµå¶û¼±
    [¿¾ ¿ë¾î] Èľ׿ͼ±
  • Posterior gluteal line
    µÚº¼±â±Ù¼±
    [¿¾ ¿ë¾î] Èĵбټ±
  • Posterior median line
    µÚÁ¤Áß¼±
    [¿¾ ¿ë¾î] ÈÄÁ¤Áß¼±
  • Trapezoid line
    ¸¶¸§Àδ뼱
    [¿¾ ¿ë¾î] ´ÉÇüÀδ뼱
  • Highest nuchal line
    ¸ÇÀ§¸ñ´ú¹Ì¼±
    [¿¾ ¿ë¾î] ÃÖ»óÇ×(¸ñ´ú¹Ì)¼±
  • Semilunar line
    ¹Ý´Þ¼±
    [¿¾ ¿ë¾î] ¹Ý¿ù¼±
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pectineal line
    Ä¡°ñ±Ù¼±
  • prosthesis cement lucent line
    Àΰø¹°½Ã¸àÆ® ¹æ»ç¼ºÅõ°ú¼±
  • reinforcement line
    °­È­¼±
  • waist line
    Ç㸮µÑ·¹, ¿äÀ§
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LCL Levinthal-Coles-Lillie [body]; lower confidence limit; lower control limit; lymphoblastoid cell line...
MCL maximum containment laboratory; medial collateral ligament; midclavicular line; midcostal line; mini...
AART American Association for Rehabilitation Therapy; American Association for Respiratory Therapy
ACT achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ...
ERT esophageal radionuclide transit; estrogen replacement therapy; examination room terminal; external r...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
F(1) first
FDI first dorsal interosseous muscle
T(1) the first
B-LCL B lymphoblastoid cell line
LCL B-lymphoblastoid cell line
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fulcrum line
    ÁöÁ¡ ¼±, Áö·¿ ¼±
  • high lip line
    »ó¼ø¼±
    À­ ÀÔ¼úÀÇ À§ÂÊ °æ°è.
  • incremental line
    ¹ßÀ°¼±
    Á¶Á÷ÀÇ °è¼ÓµÇ´Â Ä§ÂøÃþÀ» ³ªÅ¸³»´Â ¼±.
  • inferior gluteal line
    ¾Æ·¡ º¼±â±Ù ¼±
  • inferior temporal line
    ¾Æ·¡ °üÀÚ ¼±
  • interalveolar line
    ¹«Ä¡¾Ç¿¡ À־ÀÇ Ä¡Á¶Á¤°£¼±
    »óÇÏ¾Ç ¹«Ä¡¾Ç Ä¡Á¶Á¤ÀÇ ´ëÀÀºÎ¸¦ ¸Î´Â Á÷¼±À» Ä¡Á¶Á¤°£¼±À̶ó°í ÇÑ´Ù.
  • intercalar line
    Áß°£¼±
  • keratotic line
    °¢Áú¼±
  • Kerley's A line
    Äø® A¼±
  • Kerley's C line
    Äø® C¼±
  • lead line
    ¿¬¼±
    ³³ÀÌ ´Ù¸¥ ±Ý¼Ó ȤÀº °°Àº ³²°ú ÁßÇÕµÇ¾î »ý±ä ¼±.
  • line
    ¼±, °è, ÁöÇ¥, À¶¼±
    ¶§¶§·Î ¿©·¯ ÇØºÎÇÐÀû ÁöÇ¥¸¦ ¿¬°áÇÏ´Â °¡»óÀûÀÎ ¼±.
  • line angle
    ´É°¢, ¿ì°¢
    2°³ÀÇ ¸éÀÌ ¸Â´ê¾Æ¼­ ÀÌ·ç¾îÁö´Â ¼±»óÀÇ °¢Áø ºÎºÐÀ» ¸»Çϸç, ±× À̸§Àº µÎ ¸éÀÇ À̸§À» ÇÕÇØ¼­ ¾ò¾îÁø´Ù. ÀüÄ¡¿¡´Â 4°³ÀÇ ´É°¢ÀÌ ÀÖ°í ±¸Ä¡¿¡´Â 8°³ÀÇ ´É°¢ÀÌ Á¸ÀçÇÑ´Ù.
  • line focus principle
    ¼±ÃÊÁ¡ ¿ø¸®
  • line of enamel
    ¹ý¶ûÁú ¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
first rank symptoms Those symptom's that, when present, indicate that the diagnosis of schizophrenia is likely, provided that organic or toxic aetiology is ruled out: delusion of control, thought broadcasting, thought withdrawal, thought insertion, hearing one's thoughts spoken aloud, auditory hallucinations that comment on one's behaviour, and auditory hallucinations in which two voices carry on a conversation.
Synonym: first rank symptoms, schneiderian first rank symptoms.
(05 Mar 2000)
first-set rejection Allograft transplantation between two organisms not previously sensitised to the graft tissue. Necrosis of the graft usually occurs within 10 days of transplantation.
(05 Mar 2000)
first stage of labour The part of labour when the cervix dilates fully (to 10 centimeters). The first stage of labour is also called the stage of dilatation.
(12 Dec 1998)
first temporal convolution A longitudinal gyrus on the lateral surface of the temporal lobe between the lateral (sylvian) fissure and the superior temporal sulcus.
Synonym: gyrus temporalis superior, first temporal convolution, superior temporal convolution.
(05 Mar 2000)
first visceral cleft <anatomy> The cleft between the hyoid and mandibular arches of the embryo; the external auditory meatus is developed from its dorsal portion.
Synonym: first visceral cleft.
(05 Mar 2000)
acupuncture therapy Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. Heat or moxibustion and acupressure may be used in conjunction.
(12 Dec 1998)
adjuvant therapy <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells.
(14 May 1997)
alternative therapy A term given to nonconventional therapy usually given by persons who do not have a medical qualification.
(16 Dec 1997)
analytic therapy Short term for psychoanalytic therapy.
(05 Mar 2000)
Antibody Directed Enzyme Prodrug Therapy <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately.
The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects.
Acronym: ADEPT
(14 Nov 1997)
anticoagulant therapy The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting.
(05 Mar 2000)
antisense therapy Use of antisense DNA for the inhibition of translation of a specific gene product for therapeutic purposes.
(05 Mar 2000)
art therapy The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioural disorders.
(12 Dec 1998)
autoserum therapy Therapy with serum obtained from the patient's own blood.
(05 Mar 2000)
aversion therapy <psychology> A form of behaviour therapy that pairs an unpleasant stimulus with undesirable behaviour(s) so that the patient learns to avoid the latter.
See: aversive training.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • First Children
    ´ëÅë·ÉÀÇ ÀÚ³àµé
  • First Commonder
    Á¦1Æò¹Î
  • First Couple
    ´ëÅë·É ºÎó
  • First Empire
    ÇÁ¶û½ºÀÇ Á¦1Á¦Á¤ Ä¡ÇÏ
  • First Interantional
    Á¦1ÀÎÅͳ»¼Å³¯
  • First Lord
    Àå°ü;ÃÑÀç;´ë½Å
  • First Mom
    ´ëÅë·É ºÎÀÎ
  • First Republic
    ÇÁ¶û½ºÀÇ Á¦ 1°øÈ­±¹
  • First Sea Lord
    Á¦1±º»çÀ§¿ø 
  • First Secretary
    Á¦1¼­±â
  • First World
    Á¦1¼¼°è;¼±Áø °ø¾÷±¹µé
  • First World War
    =World War I
  • First day
    (Quaker±³µµ »çÀÌ¿¡¼­)ÀÏ¿äÀÏ
  • double first
    (¿µ´ëÇÐ)(Á¹¾÷½ÃÇèÀÇ)2°ú¸ñ ÃÖ°í µæÁ¡(ÀÚ)
  • first
    Á¦1ÀÇ;ÁÖ¿äÇÑ;¼öÀ§ÀÇ;Á¦ÀÏ;Àϵî;ÀÏÀ§;ÃÖÃÊ;ÃÊÇÏ·ç;ù°·Î;ÃÖÃÊ·Î;óÀ½À¸·Î;Â÷¶ó¸®;¿ÀÈ÷·Á
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á